SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Intarcia Therapeutics, Inc. and Quintiles, Inc. Finalize Innovative Alliance to Advance Global Phase 3 Program for ITCA 650 in Type 2 Diabetes